← All stocks

Natera, Inc.

NTRA Scheduled selling only
CIK 0001604821 #586 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$57.66M
$57.66M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 40 sales
Net
−$57.66M
$0.00 against sales at will

By person

17 insiders · 40 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$51.20M (35) scheduled
−$51.20M
2,127,394
1.48%
$744.60M
−12.5%
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$5.92M (4) scheduled
−$5.92M
110,859
0.0769%
$38.80M
−1.4%
Chapman Steven Leonard
CEO AND PRESIDENT
$545.04K (1) scheduled
−$545.04K
459,452
0.3187%
$160.81M
−17.5%
BOTHA ROELOF
Director
1,080,783
0.7498%
$378.28M
−17.9%
Sheena Jonathan
Director
295,274
0.2048%
$103.35M
−34.9%
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
197,257
0.1368%
$69.04M
+72.1%
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
170,073
0.1180%
$59.53M
−17.6%
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
51,637
0.0358%
$18.07M
−28.2%
HEALY JAMES
Director
46,260
0.0321%
$16.19M
+0.9%
Baynes Roy D.
Director
20,158
0.0140%
$7.06M
+28.5%
Marcus Gail Boxer
Director
7,852
0.0054%
$2.75M
−63.6%
Bertagnolli Monica
Director
7,020
0.0049%
$2.46M
ROSENMAN HERM
Director
5,927
0.0041%
$2.07M
−91.0%
Williams Brinkley Ruth
Director
5,475
0.0038%
$1.92M
+84.7%
Chapman Rowan E
Director
4,663
0.0032%
$1.63M
−41.5%
Rubin Eric H
Director
2,204
0.0015%
$771.42K
Lynch Thomas J. Jr.
Director
1,905
0.0013%
$666.76K

Nothing of that kind in this period.

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 40
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 7 Sep 2016